LUMiC Endoprosthetic Reconstruction of Periacetabular Tumor Defects
Authors:
- Richard E. EvenhuisRERichard E. Evenhuis
- Michiel A.J. van de SandeMichiel A.J. van de Sande
- Marta FioccoMFMarta Fiocco
- Demien BroekhuisDBDemien Broekhuis
- Michaël P.A. BusMBMichaël P.A. Bus
- the LUMiC® Study GroupTGthe LUMiC® Study Group
Open Access
- 23 May 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 106 (14) , 1309-1316
Abstract
Update: This article was updated on July 17, 2024 because of a previous error, which was discovered after the preliminary version of the article was posted online. The byline that had read “Richard E. Evenhuis, MD1, Michiel A.J. van de Sande, MD, PhD1,2, Marta Fiocco, PhD2,3,4, Demien Broekhuis, MD1, Michaël P.A. Bus, MD, PhD1, and the LUMiC® Study Group*” now reads “Richard E. Evenhuis, MD1, Michiel A.J. van de Sande, MD, PhD1,2, Marta Fiocco, PhD2,3,4, Edwin F. Dierselhuis, MD, PhD5, Demien Broekhuis, MD1, Michaël P.A. Bus, MD, PhD1, and the LUMiC® Study Group*”. The Department of Orthopaedic Surgery, Radboudumc, Nijmegen, The Netherlands, has been added as the affiliation for Edwin F. Dierselhuis, MD, PhD. Background: We previously reported promising early results for periacetabular tumor reconstructions using the LUMiC prosthesis. The current study evaluates mid-term complications, revision rates, cumulative incidence of implant revision, and risk factors for complications in a multicenter cohort. Methods: We assessed patients in whom a tumor defect after type P1b+2, P2, P2+3, or P1b+2+3 internal hemipelvectomy was reconstructed with a LUMiC prosthesis during the period of 2008 to 2022. Complications were reported according to the Henderson classification. Competing risks models were used to estimate the cumulative incidence of implant revision for mechanical and nonmechanical reasons, and reoperations for any complication. Cox models were used to study the effect of risk factors on dislocation and infection. Results: One hundred and sixty-six patients (median follow-up, 4.2 years [interquartile range, 2.6 to 7.6 years]) were included. A total of 114 (69%) were treated for a primary malignant tumor, 46 (28%) for metastatic carcinoma, 5 (3%) for a benign aggressive lesion, and 1 (1%) for another reason. One hundred and sixty-five reoperations were performed in 82 (49%) of the patients; 104 (63%) of the reoperations were within 6 months. Thirty-two (19%) of 166 implants were revised: 13 (8%) for mechanical reasons, mainly dislocation (n = 5, 3%), and 19 (11%) for nonmechanical reasons, mainly periprosthetic joint infection (PJI) (n = 15, 9%). The cumulative incidences of revision for mechanical reasons and PJI (Henderson 1 to 4) at 2, 5, and 10 years were 11% (95% confidence interval [CI], 7% to 17%), 18% (12% to 25%), and 24% (16% to 33%), respectively. Previous surgery at the same site was associated with an increased dislocation risk (cause-specific hazard ratio [HRCS], 3.0 [95% CI, 1.5 to 6.4]; p < 0.01), and resections involving the P3 region were associated with an increased infection risk (HRCS, 2.5 [95% CI, 1.4 to 4.7]; p < 0.01). Conclusions: Despite a substantial reoperation risk, the LUMiC prosthesis demonstrated its durability in the mid-term, with a low mechanical revision rate and most patients retaining their primary implant. Most complications occur in the first postoperative months. Patients with previous surgery at the same site had an increased dislocation risk and might benefit from more conservative rehabilitation and aftercare. Measures should be aimed at reducing the PJI risk, especially in resections involving the P3 region. Level of Evidence: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.Keywords
This publication has 28 references indexed in Scilit:
- LUMiC® endoprosthesis for pelvic reconstruction: A Canadian experienceJournal of Surgical Oncology, 2022
- Pelvic reconstruction using an ice-cream cone prosthesis: correlation between the inserted length of the coned stem and surgical outcomeInternational Journal of Clinical Oncology, 2021
- Reconstruction after periacetabular tumor resection with Lumic® endoprosthesis: What are the midterm results?Journal of Surgical Oncology, 2020
- Acetabular reconstruction with an ice‐cream cone prosthesis following resection of pelvic tumors: Does computer navigation improve surgical outcome?Journal of Surgical Oncology, 2020
- Pelvic reconstructions following peri-acetabular bone tumour resections using a cementless ice-cream cone prosthesis with dual mobility cupInternational Orthopaedics, 2018
- Comparison of dual mobility cup and other surgical construts used for three hundred and sixty two first time hip revisions due to recurrent dislocations: five year results from Lithuanian arthroplasty registerInternational Orthopaedics, 2017
- LUMiC® Endoprosthetic Reconstruction After Periacetabular Tumor Resection: Short-term ResultsClinical Orthopaedics and Related Research, 2016
- Limb-salvage reconstruction with MUTARS® hemipelvic endoprosthesis: A prospective multicenter studyEuropean Journal of Surgical Oncology, 2009
- Tutorial in biostatistics: competing risks and multi‐state modelsStatistics in Medicine, 2006
- Complications and functional evaluation of 17 saddle prostheses for resection of periacetabular tumors*Journal of Surgical Oncology, 2001